In order to implement the requirements of “carrying out skills training around professional inspector team construction” of leading Party group of the CFDA, to promote the capacity of inspectorate, and improve the professional skills and comprehensive quality of the inspectors, CFDI will hold “Experts’ Forum” in 2018 continuously. The first “Experts’ Forum” was held on February 11 successfully. At this forum, Doctor Ma Xiujing, Senior Reviewer of the Center for Drug Evaluation of CFDA (CDE), made a speech about “General Considerations on Quality Control Evaluation of Chinese Herbal Compound”.

Director of CFDI Ding Jianhua presented and made a speech for the first forum. Director Ding emphasized the importance of training and learning for improving the ability of inspectors in the critical period of the development and transition processes of current inspection work, and he pointed out that inspection work is more and more important for the supervision of CFDA, inspectors do not only need to learn the specialized knowledge of the full life circle of drugs, but also need to establish the new inspection concept based on varieties, improve inspection ability and act as the watcher to protect the safety and health of the masses.

Doctor Ma Xiujing who taught at this time is the Senior Reviewer, Chief Reviewer, Chief Pharmacist of Pharmaceutical Department of Traditional Chinese Medicine Ethnodrug of CDE. He has 30 years’ experience in Chinese pharmacological specialty, including 17 years’ experience in technical review of traditional Chinese medicine, and he is mainly undertaking the pharmacological professional review and comprehensive review of the registration applications for new traditional Chinese medicine.

Doctor Ma overviewed the laws, rules, regulations, guideline and technical standard related to traditional Chinese medicine review, mainly introduced the basic principle of traditional Chinese medicine review and basic ideology of “Quality By Design”, and introduced the key points of review of new Chinese herbal compound drugs on the aspects of selection of medicinal materials, medicinal slices and dosage forms, study of preparation technology, study on quality standard, and study on stability combining the characteristics of new Chinese herbal compound drugs. The interpretation of Doctor Ma enabled the participants to clearly understand the review principle and key points of review of Chinese herbal compound and provided important references for inspectors to carry out relevant inspection of traditional Chinese medicine.

Drug and Cosmetic Registration Office of CFDA, the Center for Food and Drug Inspection of CFDA, Center for Drug Evaluation of CFDA, the Center for Drug Certification of Beijing, the Center for Drug Review of Beijing and 24 provincial drug inspectorates from the whole country synchronously watching through video system participated in the training, totally 240 person participated in the training.